Animals and humans rapidly develop respiratory failure and die within
a few days when exposed to 100% oxygen. Postmortem examination of the
lungs shows histopathologic features characteristic of diffuse alveola
r damage, clinically recognized as adult respiratory distress syndrome
(ARDS). Ar the present rime, there is no effective therapy available
to alter outcomes in ARDS. Importantly, hypomagnesemia also is frequen
tly observed in critically ill patients at risk of developing ARDS. in
a model oi hyperoxic lung injury, rats were exposed to 100% oxygen fo
r 48, 64, and 96 hr and several experiments were performed. First, cha
nges in the features of bronchoalveolar lavage and in alveolar macroph
age function were compared in rats exposed to room air and those expos
ed to hyperoxia. Second, we studied the effect of hypomagnesemia on th
e severity of hyperoxic lung injury. Third, we evaluated the pulmonary
responses to high-dose and normal-dose Mg therapy in rats exposed to
hyperoxia. In ail groups, hyperoxia induced significant changes in the
total and differential cell counts with increased lipid peroxidation
of lavaged cells, enhanced chemiluminescence from alveolar macrophages
, and protein leakage into the alveolar spaces. After 48 hr of hyperox
ia, oxygen-free radical formation and hydrogen peroxide production by
the alveolar macrophage were diminished compared to baseline, implying
a toxic effect of hyperoxia on the alveolar macrophages. Overall, hyp
omagnesemia tended to magnify the degree of hyperoxic lung injury, whi
le high-dose Mg therapy tended to attenuate the effects of hyperoxia.
In conclusion, in this animal model of diffuse alveolar damage, altera
tions in host serum magnesium levels may modulate the degree of lung d
amage.